This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
DICE Therapeutics 미래 성장
Future 기준 확인 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for DICE Therapeutics.
주요 정보
-22.3%
수익 성장률
-14.8%
EPS 성장률
| Pharmaceuticals 수익 성장 | 27.3% |
| 매출 성장률 | 86.8% |
| 향후 자기자본 수익률 | n/a |
| 애널리스트 커버리지 | Good |
| 마지막 업데이트 | 09 Aug 2023 |
최근 미래 성장 업데이트
Recent updates
We're Not Very Worried About DICE Therapeutics' (NASDAQ:DICE) Cash Burn Rate
May 14
DICE Therapeutics positive phase 1 data for psoriasis candidate leads shares 71% higher
Oct 11Here's Why We're Not Too Worried About DICE Therapeutics' (NASDAQ:DICE) Cash Burn Situation
Sep 11DICE Therapeutics GAAP EPS of -$0.58
Aug 11DICE Therapeutics initiated at buy at Wainwright on platform for small molecule drugs
Jul 18수익 및 매출 성장 예측
| 날짜 | 수익 | 수익 | 잉여 현금 흐름 | 작전 현금 | 평균 애널리스트 수 |
|---|---|---|---|---|---|
| 12/31/2025 | 2 | -224 | -161 | -205 | 8 |
| 12/31/2024 | N/A | -169 | -161 | -155 | 9 |
| 12/31/2023 | N/A | -140 | -116 | -109 | 9 |
| 6/30/2023 | N/A | -104 | -87 | -84 | N/A |
| 3/31/2023 | N/A | -91 | -75 | -73 | N/A |
| 12/31/2022 | N/A | -84 | -67 | -64 | N/A |
| 9/30/2022 | N/A | -77 | -63 | -61 | N/A |
| 6/30/2022 | N/A | -74 | -56 | -54 | N/A |
| 3/31/2022 | 1 | -59 | -46 | -45 | N/A |
| 12/31/2021 | 1 | -49 | -40 | -39 | N/A |
| 9/30/2021 | 1 | -40 | -31 | -30 | N/A |
| 6/30/2021 | 2 | -29 | -27 | -27 | N/A |
| 3/31/2021 | 1 | -27 | -24 | -24 | N/A |
| 12/31/2020 | 1 | -24 | -21 | -21 | N/A |
| 12/31/2019 | 6 | -13 | -17 | -16 | N/A |
애널리스트 미래 성장 예측
수입 대 저축률: DICE is forecast to remain unprofitable over the next 3 years.
수익 vs 시장: DICE is forecast to remain unprofitable over the next 3 years.
고성장 수익: DICE is forecast to remain unprofitable over the next 3 years.
수익 대 시장: DICE is forecast to have no revenue next year.
고성장 수익: DICE is forecast to have no revenue next year.
주당 순이익 성장 예측
미래 자기자본 수익률
미래 ROE: Insufficient data to determine if DICE's Return on Equity is forecast to be high in 3 years time